"We need to do more research to find ways to help manage weight gain and reduce risks during pregnancy when stopping GLP-1 medications." Several authors disclosed ties to the medical technology and publishing industries
Now theyre everywhere
GLP-1 drugs significantly reduce appetite, which can cause patients to consume far fewer calories and nutrients than their bodies need
Numerous preclinical reports have highlighted the ability of curcumin to restore reduced GSH levels and the activities of GSH-related antioxidant enzymes in the myocardium after exposure to cardiotoxic factors, for example, DOX, I/R, diabetes, hyperthyroid conditions, and copper sulfate [184,185,186,187,188]
Unraveling oxyntomodulin, GLP1s enigmatic brother
the lab it tracked tested about 3,050 grey-market obesity-drug samples in 2024, up from roughly 650 the year before